Clinical Trials Logo

Thyroid clinical trials

View clinical trials related to Thyroid.

Filter by:

NCT ID: NCT05510609 Recruiting - Thyroid Cancer Clinical Trials

Three-dimensional Ultrasonography Thyroid Volume Measurement.

Start date: May 9, 2022
Phase: N/A
Study type: Interventional

The purpose of this clinical trial is to investigate the accuracy of applying three-dimensional ultrasound on thyroid gland patients when determining a gland volume. The method will be compared to conventional b-mode ultrasound where three axis measurements (length, width, and depth) are evaluated in the ellipsoid model. The three dimensional (3D) method is utilizing optical tracking connected to the ultrasound image to form cross-sectional imaging. Patients enrolled in the study are set for complete thyroidectomies enabling a true volume of the gland by water displacement after excision. The aim is to find if this 3D method is more accurate in volume estimation than the ellipsoid model.

NCT ID: NCT05501041 Enrolling by invitation - Thyroid Clinical Trials

Measuring Symptom Relief After Radiofrequency Ablation of the Thyroid

Start date: August 22, 2022
Phase:
Study type: Observational

The purpose of this study is to measure the impact of thyroid radiofrequency ablation procedure on patients with thyroid-related symptoms using a modified pre-existing scoring system.

NCT ID: NCT05434715 Completed - Thyroid Clinical Trials

Evaluation of Minimal Invasive Thyroidectomy

Start date: March 1, 2021
Phase: N/A
Study type: Interventional

The goals of minimally invasive approaches are better cosmetic results with small neck scar, decreasing postoperative pain, and shortening of hospital stay periods without postoperative complications. The concept of surgical invasiveness cannot be limited to the length and site of the skin incision; it must be extended to all structures dissected during the procedure. Conventional thyroidectomy without raising subplatysmal flaps has proven to be effective in reducing postoperative pain and seroma

NCT ID: NCT05421559 Completed - Surgery Clinical Trials

Transection of Sternothyroid Muscle Increases the Rate of Exposure of the External Laryngeal Nerve During Thyroidectomy

Start date: January 1, 2021
Phase: N/A
Study type: Interventional

The sternothyroid (ST) muscle is closely adherent to the thyroid gland with oblique insertion into the thyroid cartilage. EBSLN passes through the sternothyroid laryngeal triangle with a parallel course deep to the ST muscle. This study evaluates the transection of the sternothyroid muscle as a key step during thyroidectomy to increase the rate of exposure and visual identification of EBSLN compared to ST muscle retraction as a traditional technique.

NCT ID: NCT05328076 Active, not recruiting - Thyroid Cancer Clinical Trials

Parathyroid Vascularization During Total Thyroidectomy Using Indocyanine Green Angiography

ANGIO_PARA
Start date: May 2, 2022
Phase:
Study type: Observational

Prospective, observational, single-center study about the use of indocyanine green angiography during total thyroidectomy. The main objective of the study is to identify a quantitative score of parathyroid vascularization as an outcome of angiography that correlates with the absence of postoperative hypoparathyroidism. It is planned to enroll 66 patients.

NCT ID: NCT05323539 Completed - Thyroid Clinical Trials

Comparison of Thyroid Volumes in Patients With and Without Endometrioma

Start date: September 20, 2021
Phase: N/A
Study type: Interventional

The aim of our study is to evaluate whether there is a statistical difference between thyroid gland volume in patients with pathological diagnosis of endometriosis or endometrioma and in patients who underwent surgery for other gynecological reasons, and to reveal the presence of concomitant thyroid disease in these cases.

NCT ID: NCT05276271 Completed - Epilepsy Clinical Trials

The Effect of Levetiracetam on Lipid Profile in Children

Start date: October 1, 2020
Phase:
Study type: Observational

Levetiracetam is a widely prescribed antiseizure medication in epileptic children due to an estimated better safety profile and easy accessibility. There is limited and contradicting data about the effect of levetiracetam on serum lipid metabolisms, especially in epileptic children. The aim of our study was to evaluate the effect of levetiracetam therapy on lipid metabolism in euthyroid non-obese epileptic children. In this case-control study, the investigators recruited 37 epileptic children receiving levetiracetam monotherapy for at least 12 months and 54 healthy controls. All the participants were euthyroid and within normal nutritional status limits for their age. Fasting blood samples were obtained for serum thyroid-stimulating hormone (TSH), free triiodothyronine, free thyroxine, total cholesterol (TC), high-density lipoprotein (HDL), low-density lipoprotein (LDL), triglycerides, Triglyceride/HDL Index, uric acid, CRP, and transaminases at the administration. The investigators would like to show if epileptic children with levetiracetam monotherapy are susceptible to lipid metabolism alterations.

NCT ID: NCT05243979 Not yet recruiting - Thyroid Clinical Trials

The Relation Between Thyroid , Parathyroid Hormones and eGFR in CKD Patients in Assiut

Start date: March 1, 2022
Phase:
Study type: Observational

To evaluate the relation between thyroid, parathyroid hormones and estimated glomerular filtration rate in chronic kidney disease .

NCT ID: NCT05176184 Recruiting - Surgery Clinical Trials

A Deep Learning Method to Predict Difficult Laryngoscopy Using Cervical Spine X-ray Image

Start date: December 1, 2021
Phase:
Study type: Observational

An unanticipated difficult laryngoscopy is associated with serious airway-related complications. The investigators developed a deep learning-based model that predicts a difficult laryngoscopy (Cormack-Lehane grade 3-4) from a cervical spine lateral X-ray using data from 14,135 patients undergoing thyroid surgery. This model showed excellent predictive performance, which was higher than that of other deep learning architectures. In this study, the investigators prospectively validate the model for predicting a difficult laryngoscopy and compare predictive power with clinical airway evaluation.

NCT ID: NCT05059470 Recruiting - Thyroid Clinical Trials

IMRT Followed by Pembrolizumab in the Adjuvant Setting in Anaplastic Cancer of the Thyroid (IMPAACT): Phase II Trial Adjuvant Pembrolizumab After IMRT in ATC

Start date: February 11, 2022
Phase: Phase 2
Study type: Interventional

This is an open label, single center, phase 2 trial of adjuvant pembrolizumab after external beam radiation to the primary tumor in patients with stage IVB (disease localized to the neck) ATC. This drug trial will estimate the median progression-free survival (PFS) (from the start of adjuvant pembrolizumab until locoregional progression, development of distant metastatic disease, or death) in stage IVB ATC patients with gross disease, treated with external beam radiation (+/- concomitant chemotherapy) followed by adjuvant pembrolizumab. Patients will be patients enrolled from cohort 1 and 2 (cohort 1: ≥51 Gy; cohort 2: ≤50 Gy).